Corteva/$CTVA
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Corteva
Corteva is a crop protection pure play. The company was formed in 2019 when it was spun off from DowDuPont and spun off its seeds business, Vylor, in 2026. Corteva is a leader in the development of new crop protection products, including herbicides, insecticides, fungicides, biologicals, and plant health products. Corteva operates globally. North America generates nearly 40% of revenue while Latin America generates over 30%.
- Ticker
- $CTVA
- Sector
- Materials
- Primary listing
- NYSE
- Employees
- -
- Headquarters
- Indianapolis, United States
- Website
- www.corteva.com
Corteva Metrics
BasicAdvanced
$7.8B
12.00
$0.97
-
-
Price and volume
Market cap
$7.8B
52-week high
$90.97
52-week low
$11.25
Average daily volume
28M
Financial strength
Current ratio
1.785
Quick ratio
1.231
Long term debt to equity
0.178
Total debt to equity
0.136
Interest coverage (TTM)
7.44%
Profitability
EBITDA (TTM)
678
Gross margin (TTM)
42.11%
Net profit margin (TTM)
2.76%
Operating margin (TTM)
16.29%
Effective tax rate (TTM)
20.44%
Management effectiveness
Valuation
Price to earnings (TTM)
12.004
Price to revenue (TTM)
0.976
Price to book
0.85
Price to tangible book (TTM)
1.34
Growth
What the Analysts think about Corteva
Analyst ratings (Buy, Hold, Sell) for Corteva stock.
Analyst projections of the future price of Corteva stock.
Bulls say / Bears say
From 2020 to 2025, Corteva’s crop protection business grew revenue by more than $1 billion and expanded operating EBITDA margins by about 250 basis points. Differentiated products now make up roughly 65% of sales, supporting a stronger mix. (Corteva)
Corteva says its $11 billion pipeline includes 12 new crop protection technologies over the next decade, with potential peak revenue of about $4 billion. Successful launches could add growth and help replace products facing competition or resistance. (StockAnalysis)
With the seed business spun off, Corteva can focus on crop protection as a standalone company. Management’s plan targets about 6% annual EBITDA growth and $2.2–$2.6 billion in cash flow by 2029; delivering that would provide scope to fund innovation and returns to shareholders. (Corteva, StockAnalysis)
Crop protection sales fell 4% in the second quarter, as price dropped 4% and volume fell 2%. Competitive pricing in Latin America shows how hard it may be to protect revenue and margins. (Corteva)
PFAS-related claims create legal uncertainty around the separation, with multiple states challenging the spin-off over alleged efforts to limit access to assets. Corteva’s SEC filing also warns that some legacy legal liabilities could be material. (24/7 Wall St., SEC)
Crop protection faces political and regulatory scrutiny, which could threaten demand or raise compliance costs. Bloomberg reports that Corteva’s chief executive is defending crop chemicals amid pressure from the Trump administration and the MAHA movement. (Bloomberg)
Data summarised monthly by Lightyear AI. Last updated on 28 Oct 2026.
Corteva Financial Performance
Revenues and expenses
Corteva Earnings Performance
Company profitability
Upcoming events
Corteva News
AllArticlesVideos
Funds containing Corteva
AllUSDEURGBP
Fund name | Fund size | $CTVA weighting |
|---|---|---|
iShares Agribusiness$ISAG | $494M | 1.21% |
iShares Agribusiness£SPAG | $494M | 1.21% |
iShares Agribusiness€ISAE | $491M | 1.21% |
SPDR MSCI World Materials€WMAT | $206M | 0.26% |
SPDR S&P 400 US Mid Cap$SPY4 | $6.4B | 0.22% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.